Published Online
on May 13, 2004

A more recent version of this article appeared on June 1, 2004

This Article Full Text (PDF) All Versions of this Article: 35/6/1519    most recent 01.STR.0000128883.89984.52v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Elkind, M. S.V. Articles by Sacco, R. L. Search for Related Content PubMed PubMed Citation Articles by Elkind, M. S.V. Articles by Sacco, R. L. Related Collections Thrombin Coumarins Other anticoagulants Acute Cerebral Infarction Arrhythmias, clinical electrophysiology, drugs Embolic stroke Anticoagulants

Submitted on March 23, 2004
Accepted on April 2, 2004

Direct Thrombin Inhibition. A Novel Approach to Stroke Prevention in Patients With Atrial Fibrillation

Mitchell S.V. Elkind MD, MS^* and Ralph L. Sacco MD, MS

From the Department of Neurology (M.S.E., R.L.S.), College of Physicians and Surgeons, Columbia University, and the Columbia University Medical Center of New York-Presbyterian Hospital, New York; the Sergievsky Center (M.S.E., R.L.S.), College of Physicians and Surgeons, Columbia University, New York; and the Division of Epidemiology (R.L.S.), Joseph P. Mailman School of Public Health, Columbia University, New York.

^* To whom correspondence should be addressed. E-mail: mse13{at}columbia.edu.

Key words: atrial fibrillation • cerebral embolism • direct thrombin inhibitor • stroke prevention • ximelagatran